Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase expression predicts clinical outcome in hepatocellular carcinoma patients.

Source:http://linkedlifedata.com/resource/pubmed/id/21626328

Download in:

View as

General Info

PMID
21626328